Search Clinical Trials | Vanderbilt-Ingram Cancer Center

Filter By:
Search by Keyword:

Displaying 1 - 2 of 2

VUMC to help engage more study participants in research decisions

Human research will be more equitable, inclusive and stronger if the people who are participants in studies also help plan and guide the direction of those studies.

https://news.vumc.org/2023/10/25/vumc-to-help-engage-more-study-participants-in-research-decisions/

Wed, 10/25/2023 - 12:00

Cancer_Health_Outcomes_and_Control_Research_Program

Bill Snyder

Cancer_Health_Outcomes_and_Control_Research_Program

Locked

A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC

Lung

This is a Phase III, randomised, double-blind, placebo-controlled, multicentre, international
study assessing the efficacy and safety of durvalumab (MEDI4736) and domvanalimab (AB154)
compared with durvalumab plus placebo in adults with locally advanced (Stage III),
unresectable NSCLC whose disease has not progressed following definitive platinum-based cCRT.

Disease Sites: Lung

Phase: III

Investigator: Whitaker, Ryan

NCTID: NCT05211895

Protocol No: VICCTHO2297

Learn More